Cargando…
Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
Trauma-induced coagulopathy (TIC) is a recently described condition which traditionally has been diagnosed by the common coagulation tests (CCTs) such as prothrombin time/international normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), platelet count, and fibrinogen levels. The...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374842/ https://www.ncbi.nlm.nih.gov/pubmed/26960340 http://dx.doi.org/10.2174/1389450117666160310153211 |
_version_ | 1782518963896320000 |
---|---|
author | Walsh, Mark Fritz, Stephanie Hake, Daniel Son, Michael Greve, Sarah Jbara, Manar Chitta, Swetha Fritz, Braxton Miller, Adam Bader, Mary K McCollester, Jonathon Binz, Sophia Liew-Spilger, Alyson Thomas, Scott Crepinsek, Anton Shariff, Faisal Ploplis, Victoria Castellino, Francis J. |
author_facet | Walsh, Mark Fritz, Stephanie Hake, Daniel Son, Michael Greve, Sarah Jbara, Manar Chitta, Swetha Fritz, Braxton Miller, Adam Bader, Mary K McCollester, Jonathon Binz, Sophia Liew-Spilger, Alyson Thomas, Scott Crepinsek, Anton Shariff, Faisal Ploplis, Victoria Castellino, Francis J. |
author_sort | Walsh, Mark |
collection | PubMed |
description | Trauma-induced coagulopathy (TIC) is a recently described condition which traditionally has been diagnosed by the common coagulation tests (CCTs) such as prothrombin time/international normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), platelet count, and fibrinogen levels. The varying sensitivity and specificity of these CCTs have led trauma coagulation researchers and clinicians to use Viscoelastic Tests (VET) such as Thromboelastography (TEG) to provide Targeted Thromboelastographic Hemostatic and Adjunctive Therapy (TTHAT) in a goal directed fashion to those trauma patients in need of hemostatic resuscitation. This review describes the utility of VETs, in particular, TEG, to provide TTHAT in trauma and acquired non-trauma-induced coagulopathy. |
format | Online Article Text |
id | pubmed-5374842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-53748422017-04-12 Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy Walsh, Mark Fritz, Stephanie Hake, Daniel Son, Michael Greve, Sarah Jbara, Manar Chitta, Swetha Fritz, Braxton Miller, Adam Bader, Mary K McCollester, Jonathon Binz, Sophia Liew-Spilger, Alyson Thomas, Scott Crepinsek, Anton Shariff, Faisal Ploplis, Victoria Castellino, Francis J. Curr Drug Targets Article Trauma-induced coagulopathy (TIC) is a recently described condition which traditionally has been diagnosed by the common coagulation tests (CCTs) such as prothrombin time/international normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), platelet count, and fibrinogen levels. The varying sensitivity and specificity of these CCTs have led trauma coagulation researchers and clinicians to use Viscoelastic Tests (VET) such as Thromboelastography (TEG) to provide Targeted Thromboelastographic Hemostatic and Adjunctive Therapy (TTHAT) in a goal directed fashion to those trauma patients in need of hemostatic resuscitation. This review describes the utility of VETs, in particular, TEG, to provide TTHAT in trauma and acquired non-trauma-induced coagulopathy. Bentham Science Publishers 2016-06 2016-06 /pmc/articles/PMC5374842/ /pubmed/26960340 http://dx.doi.org/10.2174/1389450117666160310153211 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Walsh, Mark Fritz, Stephanie Hake, Daniel Son, Michael Greve, Sarah Jbara, Manar Chitta, Swetha Fritz, Braxton Miller, Adam Bader, Mary K McCollester, Jonathon Binz, Sophia Liew-Spilger, Alyson Thomas, Scott Crepinsek, Anton Shariff, Faisal Ploplis, Victoria Castellino, Francis J. Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy |
title | Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy |
title_full | Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy |
title_fullStr | Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy |
title_full_unstemmed | Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy |
title_short | Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy |
title_sort | targeted thromboelastographic (teg) blood component and pharmacologic hemostatic therapy in traumatic and acquired coagulopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374842/ https://www.ncbi.nlm.nih.gov/pubmed/26960340 http://dx.doi.org/10.2174/1389450117666160310153211 |
work_keys_str_mv | AT walshmark targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT fritzstephanie targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT hakedaniel targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT sonmichael targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT grevesarah targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT jbaramanar targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT chittaswetha targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT fritzbraxton targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT milleradam targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT badermaryk targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT mccollesterjonathon targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT binzsophia targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT liewspilgeralyson targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT thomasscott targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT crepinsekanton targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT sharifffaisal targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT ploplisvictoria targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy AT castellinofrancisj targetedthromboelastographictegbloodcomponentandpharmacologichemostatictherapyintraumaticandacquiredcoagulopathy |